Loss of c-Jun N-terminal kinase-interacting protein-1 does not affect axonal transport of the amyloid precursor protein or Aβ production

Human Molecular Genetics

Volumn 22, Issue 22, 2013, Pages 4646-4652

  Vagnoni, Alessio ^a,b   Glennon, Elizabeth B C ^a   Perkinton, Michael S ^a,c   Gray, Emma H ^a,d   Noble, Wendy ^a   Miller, Christopher C J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c MEDIMMUNE   (United States)

^d MS Society   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; AMYLOID BETA PROTEIN; C JUN N TERMINAL KINASE INTERACTING PROTEIN 1; ENHANCED GREEN FLUORESCENT PROTEIN; KINESIN 1; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FEMALE; GENE DISRUPTION; GENE LOSS; HUMAN; HUMAN TISSUE; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; RETROGRADE NERVE FIBER TRANSPORT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AXONAL TRANSPORT; AXONS; BRAIN; EMBRYO, MAMMALIAN; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MIDDLE AGED; NEURONS; RATS;

EID: 84887005627     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt313     Document Type: Article

References (62)

1. De Vos, K.J., Grierson, A.J., Ackerley, S. and Miller, C.C.J. (2008) Role of axonal transport in neurodegenerative diseases. Annu. Rev. Neurosci., 31, 151-173.
2. Chevalier-Larsen, E. and Holzbaur, E.L. (2006) Axonal transport and neurodegenerative disease. Biochim. Biophys. Acta, 1762, 1094-1108.
3. Morfini,G.A.,Burns,M.,Binder,L.I.,Kanaan,N.M.,LaPointe,N.,Bosco,D.A., Brown, R.H. Jr., Brown, H., Tiwari, A., Hayward, L. et al. (2009) Axonal transport defects in neurodegenerative diseases. J. Neurosci., 29, 12776- 12786.
4. Millecamps, S. and Julien, J.P. (2013) Axonal transport deficits and neurodegenerative diseases. Nat. Rev. Neurosci., 14, 161-176.
5. De Strooper, B., Vassar, R. and Golde, T. (2010) The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol., 6, 99-107.
6. Randall, A.D., Witton, J., Booth, C., Hynes-Allen, A. and Brown, J.T. (2010) The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. Neuropharmacology, 59, 243-267.
7. Walsh, D.M. and Selkoe, D.J. (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron, 44, 181-193.
8. Stokin, G.B., Lillo, C., Falzone, T.L., Brusch, R.G., Rockenstein, E., Mount, S.L., Raman, R., Davies, P., Masliah, E., Williams, D.S. et al. (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science, 307, 1282-1288.
9. Vagnoni, A., Perkinton, M.S., Gray, E.H., Francis, P.T., Noble, W. and Miller, C.C.J. (2012) Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates Abeta production. Hum. Mol. Genet., 21, 2845-2854.
10. Steuble, M., Diep, T.M., Schatzle, P., Ludwig, A., Tagaya, M., Kunz, B. and Sonderegger, P. (2012) Calsyntenin-1 shelters APP from proteolytic processing during anterograde axonal transport. Biol. Open, 1, 761-774.
11. Decker, H., Lo, K.Y., Unger, S.M., Ferreira, S.T. and Silverman, M.A. (2010) Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons. J. Neurosci., 30, 9166-9171.
12. Hiruma, H., Katakura, T., Takahashi, S., Ichikawa, T. and Kawakami, T. (2003) Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J. Neurosci., 23, 8967-8977.
13. Kasa, P., Papp, H., Kovacs, I., Forgon, M., Penke, B. and Yamaguchi, H. (2000) Human amyloid-beta1-42 applied in vivo inhibits the fast axonal transport of proteins in the sciatic nerve of rat. Neurosci. Lett., 278, 117-119.
14. Pigino, G., Morfini, G., Atagi, Y., Deshpande, A., Yu, C., Jungbauer, L., Ladu, M., Busciglio, J. and Brady, S. (2009) Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc. Natl Acad. Sci. USA, 106, 5907-5912.
15. Rui, Y., Tiwari, P., Xie, Z. and Zheng, J.Q. (2006) Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J. Neurosci., 26, 10480-10487.
16. Wang, X., Perry, G., Smith, M.A. and Zhu, X. (2010) Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neurodegenerative Diseases, 7, 56-59.
17. Zempel, H., Thies, E., Mandelkow, E. and Mandelkow, E.M. (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous tau into dendrites, tau phosphorylation, and destruction of microtubules and spines. J. Neurosci., 30, 11938-11950.
18. Kaether, C., Skehel, P. and Dotti, C.G. (2000) Axonalmembrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. Mol. Biol. Cell, 11, 1213-1224.
19. Szodorai, A., Kuan, Y.H., Hunzelmann, S., Engel, U., Sakane, A., Sasaki, T., Takai, Y., Kirsch, J., Muller, U., Beyreuther, K. et al. (2009) APP Anterograde transport tequires Rab3A GTPase activity for assembly of the transport vesicle. J. Neurosci., 29, 14534-14544.
20. Brunholz, S., Sisodia, S., Lorenzo, A., Deyts, C., Kins, S. and Morfini, G. (2011) Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells. Exp. Brain Res., 217, 353-364.
21. Hirokawa, N., Noda, Y., Tanaka, Y. and Niwa, S. (2009) Kinesin superfamily motor proteins and intracellular transport. Nat. Rev. Mol. Cell Biol., 10, 682-696.
22. Falzone, T.L., Stokin, G.B., Lillo, C., Rodrigues, E.M., Westerman, E.L., Williams, D.S. and Goldstein, L.S. (2009) Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects. J. Neurosci., 29, 5758-5767.
23. Kamal, A., Stokin, G.B., Yang, Z.H., Xia, C.H. and Goldstein, L.S.B. (2000) Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron, 28, 449-459.
24. Lazarov,O.,Morfini,G.A.,Lee,E.B., Farah,M.H.,Szodorai,A.,Deboer, S.R., Koliatsos, V.E.,Kins, S.,Lee,V.M.,Wong,P.C. et al. (2005)Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J. Neurosci., 25, 2386-2395.
25. Ludwig, A., Blume, J., Diep, T.M., Yuan, J., Mateos, J.M., Leuthauser, K., Steuble, M., Streit, P. and Sonderegger, P. (2009) Calsyntenins mediateTGN exit of APP in a kinesin-1-dependent manner. Traffic, 10, 572-589.
26. Konecna, A., Frischknecht, R., Kinter, J., Ludwig, A., Steuble, M., Meskenaite, V., Indermuhle, M., Engel, M., Cen, C., Mateos, J.M. et al. (2006) Calsyntenin-1 docks vesicular cargo to kinesin-1. Mol. Biol. Cell, 17, 3651-3663.
27. Araki, Y., Kawano, T., Taru, H., Saito, Y., Wada, S., Miyamoto, K., Kobayashi, H., Ishikawa, H.O., Ohsugi, Y., Yamamoto, T. et al. (2007) The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport. EMBO J., 26, 1475-1486.
28. Dodding, M.P., Mitter, R., Humphries, A.C. and Way, M. (2011) Akinesin-1 binding motif in vaccinia virus that is widespread throughout the human genome. EMBO J., 30, 4523-4538.
29. Vagnoni, A., Rodriguez, L., Manser, C., De Vos, K.J. and Miller, C.C.J. (2011) Phosphorylation of kinesin light chain-1 at serine-460 modulates binding and trafficking of calsyntenin-1. J. Cell Sci., 124, 1032-1042.
30. Kawano, T., Araseki, M., Araki, Y., Kinjo, M., Yamamoto, T. and Suzuki, T. (2012) A small peptide sequence is sufficient for initiating Kinesin-1 activation through part of TPR region of KLC1. Traffic, 13, 834-848.
31. Horiuchi, D., Collins, C.A., Bhat, P., Barkus, R.V., Diantonio, A. and Saxton, W.M. (2007) Control of a kinesin-cargo linkage mechanismby JNK pathway kinases. Curr. Biol., 17, 1313-1317.
32. Muresan, Z. and Muresan, V. (2005) Coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1. J. Cell Biol., 171, 615-625.
33. Kuan, Y.H., Gruebl, T., Soba, P., Eggert, S., Nesic, I., Back, S., Kirsch, J., Beyreuther, K. and Kins, S. (2006) PAT1a Modulates intracellular transport and processing of amyloid precursor protein (APP), APLP1, and APLP2. J. Biol. Chem., 281, 40114-40123.
34. Zheng, P., Eastman, J., Vande Pol, S. and Pimplikar, S.W. (1998) PAT1, A microtubule-interacting protein, recognizes the basolateral sorting signal of amyloid precursor protein. Proc. Natl Acad. Sci. USA, 95, 14745-12750.
35. Matsuda, S., Matsuda, Y. and D'Adamio, L. (2003) Amyloid beta protein precursor (AbetaPP), but not AbetaPP like protein-2, is bridged to the kinesin light chain by the scaffold JNK-interacting protein 1. J. Biol. Chem., 278, 38601-38606.
36. Inomata, H., Nakamura, Y., Hayakawa, A., Takata, H., Suzuki, T., Miyazawa, K. and Kitamura, N. (2003) A scaffold protein JIP-1b enhances amyloid precursor protein phosphorylation by JNK and its association with kinesin light chain 1. J. Biol. Chem., 278, 22946-22955.
37. Verhey,K.J., Meyer,D.,Deehan, R., Blenis, J., Schnapp, B.J.,Rapoport, T.A. andMargolis,B. (2001) Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J. Cell Biol., 152, 959-970.
38. Horiuchi, D., Barkus, R.V., Pilling, A.D., Gassman, A. and Saxton, W.M. (2005) APLIP1, A kinesin binding JIP-1/JNK scaffold protein, influences the axonal transport of both vesicles and mitochondria in Drosophila. Curr. Biol., 15, 2137-2141.
39. Matsuda, S., Yasukawa, T., Homma, Y., Ito, Y., Niikura, T., Hiraki, T., Hira, S., Ohno, S., Kita, Y., Kawasumi, M. et al. (2001) c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK. J. Neurosci., 21, 6597-6607.
40. Taru, H., Iijima, K., Hase, M., Kirino, Y., Yagi, Y. and Suzuki, T. (2002) Interaction of Alzheimer's beta-amyloid precursor family proteins with scaffold proteins of the JNK signaling cascade. J. Biol. Chem., 277, 20070-20078.
41. Taru, H., Kirino, Y. and Suzuki, T. (2002) Differential roles of JIP scaffold proteins in the modulation of amyloid precursor protein metabolism. J. Biol. Chem., 277, 27567-27574.
42. Dajas-Bailador, F., Jones, E.V. and Whitmarsh, A.J. (2008) The JIP1 scaffold protein regulates axonal development in cortical neurons. Curr. Biol., 18, 221-226.
43. D'Ambrosio, C., Arena, S., Fulcoli, G., Scheinfeld, M.H., Zhou, D., D'Adamio, L. and Scaloni, A. (2006) Hyperphosphorylation of JNK-interacting protein 1, a protein associated with Alzheimer disease. Mol. Cell. Proteomics, 5, 97-113.
44. Dovey, H.F., John, V., Anderson, J.P., Chen, L.Z., Andrieu, P.D., Fang, L.Y., Freedman, S.B., Folmer, B., Goldbach, E., Holsztynska, E.J. et al. (2001) Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J. Neurochem., 76, 173-181.
45. Ackerley, S., Thornhill, P., Grierson, A.J., Brownlees, J., Anderton, B.H., Leigh, P.N., Shaw, C.E. and Miller, C.C.J. (2003) Neurofilament heavy chain side-arm phosphorylation regulates axonal transport of neurofilaments. J. Cell Biol., 161, 489-495.
46. Goldsbury, C., Mocanu, M.M., Thies, E., Kaether, C., Haass, C., Keller, P., Biernat, J., Mandelkow, E. and Mandelkow, E.M. (2006) Inhibition of APP trafficking by tau protein does not increase the generation of amyloid-beta peptides. Traffic, 7, 873-888.
47. Rodrigues, E.M., Weissmiller, A.M. and Goldstein, L.S. (2012) Enhanced beta-secretase processing alters APP axonal transport and leads to axonal defects. Hum. Mol. Genet., 21, 4587-4601.
48. Mandelkow, E.M., Thies, E., Trinczek, B., Biernat, J. and Mandelkow, E. (2004) MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J. Cell Biol., 167, 99-110.
49. Araki, Y., Tomita, S., Yamaguchi, H., Miyagi, N., Sumioka, A., Kirino, Y. and Suzuki, T. (2003) Novel cadherin-related membrane proteins, Alcadeins, enhance the X11-like protein-mediated stabilization of amyloid beta -protein precursor metabolism. J. Biol. Chem., 278, 49448-49458.
50. Hill,K., Li,Y.,Bennett, M.,McKay,M.,Zhu,X.,Shern, J., Torre, E.,Lah, J.J., Levey, A.I. and Kahn, R.A. (2003)Munc18 interacting proteins: ADP-ribosylation factor-dependent coat proteins that regulate the traffic of beta-Alzheimer's precursor protein. J. Biol. Chem., 278, 36032-36040.
51. McLoughlin, D.M. and Miller, C.C.J. (1996) The intracellular cytoplasmic domain of the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine binding domain proteins in the yeast two-hybrid system. FEBS Lett., 397, 197-200.
52. Tomita, S.,Ozaki, T.,Taru,H.,Oguchi, S., Takeda, S.,Yagi, Y., Sakiyama, S., Kirino, Y. and Suzuki, T. (1999) Interaction of a neuron-specific protein containing PDZ domains withAlzheimer's amyloid precursor protein. J. Biol. Chem., 274, 2243-2254.
53. Lee, J.H., Lau, K.F., Perkinton, M.S., Standen, C.L., Rogelj, B., Falinska, A., McLoughlin, D.M. and Miller, C.C. (2004) The neuronal adaptor protein X11beta reduces Abeta levels and amyloid plaque formation in the brains of transgenic mice. J. Biol. Chem., 279, 49099-49104.
54. Mitchell, J.C., Ariff,B.B.,Yates,D.M., Lau,K.F.,Perkinton,M.S.,Rogelj,B., Stephenson, J.D.,Miller,C.C. andMcLoughlin,D.M. (2009)X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice. Hum. Mol. Genet., 18, 4492-4500.
55. Sano, Y., Syuzo-Takabatake, A., Nakaya, T., Saito, Y., Tomita, S., Itohara, S. and Suzuki, T. (2006) Enhanced amyloidogenic metabolismof APP in the X11L-deficient mouse brain. J. Biol. Chem., 281, 37853-37860.
56. Ittner, L.M., Ke, Y.D. and Gotz, J. (2009) Phosphorylated tau interacts with c-JUN N-terminal kinase (JNK) interacting protein 1 (JIP1) in Alzheimer's disease. J. Biol. Chem., 284, 20909-20916.
57. Hata, S., Fujishige, S., Araki, Y., Taniguchi, M., Urakami, K., Peskind, E., Akatsu, H., Araseki, M., Yamamoto, K., Martins, R.N. et al. (2011) Alternative processing of gamma-secretase substrates in common forms of mild cognitive impairment and Alzheimer's disease: evidence for gamma-secretase dysfunction. Ann. Neurol., 69, 1026-1031.
58. Hata, S., Taniguchi, M., Piao, Y., Ikeuchi, T., Fagan, A.M., Holtzman, D.M., Bateman, R., Sohrabi, H.R., Martins, R.N., Gandy, S. et al. (2012) Multiple gamma-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer's disease subjects. Mol. Neurodegener., 7, 16.
59. De Vos, K.J., Chapman, A.L., Tennant, M.E., Manser, C., Tudor, E.L., Lau, K.F., Brownlees, J., Ackerley, S., Shaw, P.J.,McLoughlin, D.M. et al. (2007) Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet., 16, 2720-2728.
60. Cousins, S.L., Hoey, S.E., Stephenson, F.A. and Perkinton, M.S. (2009) Amyloid precursor protein 695 assocoates with assembled NR2A- and NR2B-containingNMDAreceptors to result in the enhancement of their cell surface delivery. J. Neurochem., 111, 1501-1513.
61. Hao, C.Y., Perkinton, M.S., Chan, W.W., Chan, H.Y., Miller, C.C. and Lau, K.F. (2011) GULP1Is a novelAPP-interacting protein that altersAPP processing. Biochem. J., 436, 631-639.
62. Morotz, G.M., De Vos, K.J., Vagnoni, A., Ackerley, S., Shaw, C.E. and Miller, C.C.J. (2012) Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum. Mol. Genet., 21, 1979-1988.